Center for Drug Evaluation and Research (CDER)/Office of Clinical Pharmacology (OCP)/Division of Infectious Disease Pharmacology (DIDP) Led a regulatory research project involving clinical pharmacology and drug development.- Anti-Infective Drug Penetration into Pulmonary ELF

Development of various in vitro diagnostic (IVD) real-time reverse transcriptase polymerase chain reaction (RT-PCR) test kits for COVID-19, FluA, FluB, and RSV detection. - Novaplex™ SARS-CoV-2/P681R Assay- Novaplex™ SARS-CoV-2 Variants IV Assay - RSV OM- Novaplex™ FluA/FluB/RSV AssayParticipated in the overall process of R&D product development 1) Performed primer/probe design to optimize the assay reagents2) Prepared for and performed various Real-time PCR experiments from feasibility to pre-V&V (Verification and Validation) processes for FDA approval3) Analyzed the results of experiments in molecular biology such as cloning and sequencing.4) Organized and analyzed the acquired data using MS Excel and JMP.5) Prepared feasibility reports and documents in design history files (DHF).

participated in research on examining the phosphorylation level of Vinculin Y822 in a breast epithelial cell line under force experiments.

Prepared various media (liquid and plates) for the growth of yeasts.Maintained records, performed scientific calculations, and organized an inventory of the media.